Cargando…

Mavrilimumab for severe COVID-19

Detalles Bibliográficos
Autores principales:	Pourhoseingholi, Mohamad Amin, Shojaee, Sajad, Ashtari, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834396/ https://www.ncbi.nlm.nih.gov/pubmed/33521662 http://dx.doi.org/10.1016/S2665-9913(20)30307-6

Ejemplares similares

Mavrilimumab for severe COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Three potential challenges in studying COVID-19 pandemic data: Chinese statistics, social media, and preprint servers
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2020)

Predicting the mortality due to Covid-19 by the next month for Italy, Iran and South Korea; a simulation study
por: Shojaee, Sajad, et al.
Publicado: (2020)

A cluster analysis of epidemiological and clinical factors associated with the accumulation process of the burden of COVID-19 in European countries
por: Shojaee, Sajad, et al.
Publicado: (2021)

Comparison of the severity of psychological distress among four groups of an Iranian population regarding COVID-19 pandemic
por: Vahedian-Azimi, Amir, et al.
Publicado: (2020)

Bayesian adjustment for trend of colorectal cancer incidence in misclassified registering across Iranian provinces
por: Shojaee, Sajad, et al.
Publicado: (2018)

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2013)

Does context have a dramatic effect on results of mental health outcomes of ICU and non-ICU healthcare workers during the Coronavirus disease 2019 (COVID-19) outbreak?
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2022)

Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
por: Crotti, Chiara, et al.
Publicado: (2017)

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
por: De Luca, Giacomo, et al.
Publicado: (2020)

Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2014)

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis
por: Di Franco, Manuela, et al.
Publicado: (2014)

A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
por: Weinblatt, Michael E., et al.
Publicado: (2017)

Model‐Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab
por: Wang, Bing, et al.
Publicado: (2017)

Annual Registry for Hepatitis C and Hepatitis B is Needed for Predicting the Burden of Hepatocellolar Carcinoma in Iran
por: Fazeli, Zeinab, et al.
Publicado: (2013)

Iranian high risk regions due to esophageal cancer: spatial analysis of cancer registry data
por: Najafimehr, Hadis, et al.
Publicado: (2018)

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial
por: Cremer, Paul C, et al.
Publicado: (2021)

Metabolic Syndrome, Gastric Cancer Mortality and Competing Risk Survival Analysis
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2016)

Computed tomographic features of coronavirus disease-2019 (COVID-19) pneumonia in three groups of Iranian patients: A single center study()
por: Ashtari, S., et al.
Publicado: (2021)

Características en tomografía computarizada de la neumonía por coronavirus-2019 (COVID-19) en tres grupos de pacientes iraníes: estudio de un solo centro
por: Ashtari, S., et al.
Publicado: (2021)

The prevalence of Helicobacter pylori is decreasing in Iranian patients
por: Ashtari, Sara, et al.
Publicado: (2015)

Mortality trends of gastrointestinal cancers in Iranian population
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2013)

Systematic review of pancreatic cancer epidemiology in Asia-Pacific Region: major patterns in GLOBACON 2012
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2017)

Biological and Clinical Relevance of Long Non-Coding RNA PCAT-1 in Cancer, A Systematic Review and Meta-Analysis
por: Talebi, Atefeh, et al.
Publicado: (2019)

Estimation of average diagnosis and treatment costs of hepatitis C
por: Ashtari, Sara, et al.
Publicado: (2012)

Effectiveness of Mavrilimumab in Viral Infections Including SARS-CoV-2 Infection - A Brief Review
por: Bhatt, Kinal, et al.
Publicado: (2021)

Evaluated outcomes in patients with Chronic Hepatitis C
por: Ashtari, Sara, et al.
Publicado: (2013)

Using statistical models to assess medical cost of hepatitis C virus
por: Vahedi, Mohsen, et al.
Publicado: (2012)

Corona Covid-19 virus and severe hypoxia in young patients without underlying disease: High prevalence rate with blood group A
por: Solhpour, Ali, et al.
Publicado: (2020)

Trend of hepatocellular carcinoma incidence after Bayesian correction for misclassified data in Iranian provinces
por: Hajizadeh, Nastaran, et al.
Publicado: (2017)

Trend of Gastric Cancer after Bayesian Correction of Misclassification Error in Neighboring Provinces of Iran
por: Hajizadeh, Nastaran, et al.
Publicado: (2019)

Ruxolitinib and Severe COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Hypertension and severe COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Polymorphisms and Severity of COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
por: Cid, Maria C, et al.
Publicado: (2022)

The effects of IL-8, IL- 6, and IL-1 on the risk of celiac disease: a Bayesian regression analysis
por: Nasserinejad, Maryam, et al.
Publicado: (2019)

Severe COVID-19 in an Infant with Severe Acute Malnutrition
por: Beniwal, Neetu, et al.
Publicado: (2021)

History of upper gastrointestinal cancers in relatives: a community-based estimate
por: Moghimi-Dehkordi, Bijan, et al.
Publicado: (2012)

The role of Human leukocyte antigen class I on patient survival in Gastrointestinal cancers: a systematic review and meta- analysis
por: Najafimehr, Hadis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r7a0ksu00rgcn31d52i42l49r5